77. Biosimilars are not generic biologics. Guest, Jordan Paradise.




The Week in Health Law show

Summary: Loyola Chicago law professor Jordan Paradise joins us to discuss some of her recent work in life sciences law. We start with a review of some of the regulatory issues involving e-cigarettes and discuss the 2016 FDA regulations. We then move into a discussion of FDA regulation of biologics and biosimilars and Jordan explains naming and substitution issues.